INTRODUCTION {#s1}
============

Ovarian cancer is considered the sixth most commonly diagnosed cancer among women and the second cause of gynecologic cancer mortality worldwide \[[@R1], [@R2]\]. The prognosis of ovarian cancer is poor, with the initial diagnosis in most patients made at an advanced stage \[[@R3], [@R4]\]. The noticeable relationship between ovarian cancer incidence and geographical regions suggested that dietary habits and ethnic variations are potentially modifiable factors \[[@R5]\], whose etiologic role in ovarian cancer risk, however, remains undefined \[[@R6]\].

Dietary fat, as one of the most controversial dietary factors in nutritional epidemiology, has been reported with positive correlations with breast \[[@R7]\] and gastric \[[@R8]\] cancers in two recent meta-analyses, and elevated ovarian cancer risk in early ecologic studies \[[@R5], [@R9]\]. Although multiple epidemiologic studies have explored the associations between dietary fat consumption and risk of ovarian cancer, no definite conclusion have been drawn, and the dietary fat varieties as well as pathological types of ovarian cancer increase the complexity of this research topic. The results of two meta-analyses \[[@R10], [@R11]\] and a pooled analysis \[[@R12]\] that included data from 12 cohort studies also reached inconsistent conclusions. Therefore, we conducted a meta-analysis of case-control and cohort studies with more-detailed analyses of 1) the epidemiologic evidence regarding the association of dietary fat consumption with risk of ovarian cancer, 2) the association between dietary fat intake and the risk of ovarian cancer and pathological subtypes. This analysis was based on dietary fat types, and we extended the previous analyses \[[@R10], [@R11]\] with more included studies and dietary fat types, and an assessment stratified by EOC histology.

RESULTS {#s2}
=======

We found 1421 publications from the electronic and manual literature searches. Thirty-three potentially relevant publications \[[@R16]--[@R31]\] \[[@R32]--[@R47]\] \[[@R48]\] appeared to meet the specified protocol inclusion criteria after initial screening. Through further reading, six publications \[[@R41]--[@R46]\] contained no relevant dietary fat; two publications \[[@R47], [@R48]\] were excluded for design and dietary fat classification. Two American publications \[[@R17], [@R18]\] assessed the same study population, and eligible data were extracted from both; two Chinese publications were treated likewise \[[@R25], [@R28]\] (Figure [1](#F1){ref-type="fig"}).

![Flow chart](oncotarget-07-37390-g001){#F1}

Finally, Twenty-five publications \[[@R16]--[@R31]\] \[[@R32]--[@R40]\], including sixteen case-control \[[@R16]--[@R31]\] (Table [1](#T1){ref-type="table"}) and nine cohort \[[@R32]--[@R40]\] (Table [2](#T2){ref-type="table"}) studies were included in the analysis of dietary fat intake and ovarian cancer risk. Results were separated by dietary fat types, including total, saturated, monounsaturated, polyunsaturated, animal, plant, dairy fat, and trans-fats.

###### The characteristics and relative risks \[RRs; 95% confidence interval (CI)\] for case-control studies on dietary fat and ovarian cancer

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author(Country)                       Publication yr     Case/Control   Type of Fat                          RR (95% CI)          Adjusted confounding factors
  ------------------------------------- ------------------ -------------- ------------------------------------ -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Cramer\[[@R16]\] (America)            1984 (1978-1981)   215/215        Animal fat                           1.83 (1.00-3.38)     Weight/height^2^

  Risch\[[@R17], [@R18]\] (Canada)      1994 (1989-1992)   450/564        Total fat\                           1.16 (0.86-1.57)\    Age, total calorie intake, no. of full-term pregnancies, duration of OC use
                                                                          Saturated fat\                       1.23 (0.97-1.58)\    
                                                                          Monounsaturated fat\                 1.07 (0.90-1.27)\    
                                                                          Polyunsaturated fat                  0.86 (0.69-1.07)     

  Shu\[[@R19]\] (China)                 1989 (1984-1986)   172/172        Total fat\                           1.9 (1.2-4.4)\       income, no. of live births, history of ovarian cysts, smoking history, OC use, IUD use, tubal ligation
                                                                          Animal fat\                          1.7 (1.0-3.2)\       
                                                                          Plant fat                            0.8 (0.4-1.4)        

  Slattery\[[@R20]\] (America)          1989 (1984-1987)   85/492         Total fat\                           1.3 (0.7-2.3)\       Age, BMI, no. of pregnancies
                                                                          Saturated fat\                       1.3 (0.6-2.6)\       
                                                                          Monounsaturated fat\                 1.3 (0.7-2.3)\       
                                                                          Polyunsaturated fat                  1.2 (0.6-2.3)        

  Tzonou\[[@R21]\] (Greece)             1993 (1989-1991)   189/200        Total fat\                           0.97 (0.76-1.24)\    Age, years of schooling, parity, age at 1st birth, menopausal status, energy intake
                                                                          Saturated fat Monounsaturated fat\   1.17 (0.88-1.55)\    
                                                                          Polyunsaturated fat                  0.86 (0.71-1.05)\    
                                                                                                               0.95 (0.77-1.17)     

  La Vecchia\[[@R22]\] (Italy)          1987 (1983-1986)   455/1385       Total fat                            2.14 (1.59-2.88)     Age, interviewer, marital status, social class, education, parity, age at 1st birth, age at menarche, menopausal

  Webb\[[@R23]\] (Australia)            1998 (1990-1993)   824/1132       Total fat                            1.86 (1.03-3.37)     Age, education, BMI, smoking, parity, OC use, total energy intake

  Pan\[[@R24]\] (Canada)                2004 (1994-1997)   442/2135       Total fat\                           1.21 (0.88-1.65)\    Age, residence, education, alcohol consumption, smoking, BMI, caloric intake, recreational physical activity, number of live births, menstruation years, and menopause status
                                                                          Saturated fat\                       1.06 (0.78-1.45)\    
                                                                          Monounsaturated fat\                 1.26 (0.92-1.72)\    
                                                                          Polyunsaturated fat                  1.28 (0.94-1.76)     

  Zhang\[[@R25]\] (China)               2002 (1999-2000)   254/652        Animal fat\                          4.55 (2.2-9.3)\      Age, residence, education, alcohol consumption, smoking, BMI, tube ligation, menopause status
                                                                          Plant fat                            1.03 (0.6-1.9)       

  McCann\[[@R26]\] (America)            2003 (1986-1991)   124/696        Total fat\                           1.51 (0.57--4.02)\   Age, education, total months menstruating, difficulty becoming pregnant, OC use, menopausal status and total energy intake
                                                                          Saturated fatty acid\                1.46 (0.68--3.15)\   
                                                                          Monounsaturated fat\                 1.77 (0.73--4.31)\   
                                                                          Polyunsaturated fat                  0.63 (0.28--1.41)    

  Merritt\[[@R27]\] (America)           2014 (1992-2008)   1872/1978      Total fat\                           1.07 (0.89-1.29)\    Age, study centre (MA, NH), study phase, number of pregnancies, OC use, family history of ovarian cancer tubal ligation
                                                                          Animal fat\                          1.04 (0.87-1.26)\    
                                                                          Dairy fat\                           0.95 (0.79-1.14)\    
                                                                          Saturated fat\                       1.11 (0.92-1.34)\    
                                                                          Plant fat\                           0.98 (0.81-1.17)\    
                                                                          Trans fat\                           1.30 (1.08-1.57)\    
                                                                          Monounsaturated fat\                 0.97 (0.81-1.18)\    
                                                                          Polyunsaturated fat                  0.82 (0.68-0.99)     

  Zhang\[[@R28]\] (China)               2003 (1999-2000)   254/652        Total fat                            2.17 (1.26-3.75)     Age, locality, education, family income, BMI, total energy intake, tobacco smoking, alcohol, parity, menopausal status, OC use

  Salazar-Martinez\[[@R29]\] (Mexico)   2002 (1995-1997)   84/629         Total fat\                           0.60 (0.33-1.06)\    Age, weight change, total energy intake, number of live births, physical activity, diabetes
                                                                          Saturated fat\                       0.56 (0.31-1.02)\    
                                                                          Monounsaturated fat\                 0.54 (0.30-0.99)\    
                                                                          Polyunsaturated fat\                 0.61 (0.34-1.11)\    
                                                                          Animal fat\                          0.66 (0.37-1.19)\    
                                                                          Plant fat                            0.81 (0.46-1.45)     

  Chiaffarino\[[@R30]\] (Italy)         2007 (1992-1999)   750/2411       Monounsaturated fat\                 0.80 (0.66-0.96)\    education, parity, oral contraceptive use, family history of ovarian and/or breast cancer in first degree relatives
                                                                          Polyunsaturated fat                  0.96 (0.76-1.21)     

  Hu\[[@R31]\] (Canada)                 2011 (1994-1997)   442/5039       Trans fat                            1.04 (0.68-1.58)     Age, province, education, BMI, alcohol drinking, pack-year smoking, total of vegetable and fruit intake, monounsaturated fat, polyunsaturated fat, total energy intake, number of live births and years of menstruation
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### The characteristics and relative risks \[RRs; 95% confidence interval (CI)\] for cohort studies on dietary fat and ovarian cancer

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author (Country)                  Publication yr     Case/Total    Type of Fat            RR (95% CI)         Adjusted confounding factors
  --------------------------------- ------------------ ------------- ---------------------- ------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Merritt\[[@R32]\] (America)       2014 (1980-2009)   764/95452     Dairy fat              1.01 (0.80-1.27)    Caloric intake, number of pregnancies, parity, OC use, menopausal status, tubal ligation, family history

  Bertone\[[@R33]\] (America)       2002 (1980-1996)   301/80258     Total fat\             1.03 (0.72-1.45)\   Age, parity, age at menarche, OC use, menopausal status, postmenopausal hormone use, tubal ligation, smoking status
                                                                     Animal fat\            0.95 (0.66-1.38)\   
                                                                     Dairy fat\             1.06 (0.73-1.54)\   
                                                                     Saturated fat\         0.91 (0.62-1.32)\   
                                                                     Plant fat\             0.98 (0.68-1.43)\   
                                                                     Monounsaturated fat\   1.07 (0.75-1.52)\   
                                                                     Polyunsaturated fat\   1.14 (0.79-1.63)\   
                                                                     Trans fat              1.03 (0.72-1.47)    

  Merritt\[[@R34]\] (Europe)        2014               1095/325007   Total fat\             1.16 (0.96-1.40)\   OC use, number of children, menopausal status at enrolment, total energy intake
                                                                     Animal fat\            0.96 (0.80-1.15)\   
                                                                     Plant fat\             1.22 (0.98-1.52)\   
                                                                     Saturated fat\         1.17 (0.97-1.40)\   
                                                                     Monounsaturated fat\   1.16 (0.93-1.44)\   
                                                                     Polyunsaturated fat    1.22 (1.02-1.48)    

  Blank\[[@R35]\] (America)         2012 (1995-2005)   695/151552    Total fat\             1.28 (1.01-1.63)\   Age, race, education, BMI, family history, OC use, parity, menopausal hormone therapy use, total energy intake
                                                                     Animal fat\            1.30 (1.02-1.66)\   
                                                                     Plant fat\             1.00 (0.79-1.27)\   
                                                                     Saturated fat\         1.03 (0.71-1.50)\   
                                                                     Monounsaturated fat\   1.01 (0.63-1.60)\   
                                                                     Polyunsaturated fat    1.28 (0.92-1.77)    

  Kiani\[[@R36]\] (America)         2006 (1976-1992)   71/ 13,281    Dairy fat              0.94 (0.70-1.27)    Age, parity and BMI, and also for age at menopause and hormone replacement therapy in postmenopausal analyses

  Mommers\[[@R37]\] (Netherlands)   2006 (1986-1997)   252/2216      Dairy fat              1.53 (1.00-2.36)    Age, height, smoking, number of cigarettes smoked daily, OC use and parity, and dairy products

  Kushi\[[@R38]\] (America)         1999 (1986-1995)   139/ 29,083   Total fat\             0.80 (0.47-1.36)\   Age, total energy intake, no. of live births, age at menopause, family history of ovarian cancer, hysterectomy, waist-to-hip ratio, level of physical activity, smoking, education
                                                                     Animal fat\            0.98 (0.57-1.69)\   
                                                                     Saturated fat\         1.17 (0.69-1.97)\   
                                                                     Plant fat\             0.75 (0.44-1.27)\   
                                                                     Monounsaturated fat\   0.65 (0.38-1.13)\   
                                                                     Polyunsaturated fat    0.63 (0.38-1.03)    

  Chang\[[@R39]\] (America)         2007 (1995-2003)   280/97275     Total fat\             0.85 (0.58-1.24)\   Race, energy intake, parity, OC use, exercise, wine consumption, menopausal status, hormone therapy
                                                                     Saturated fat          0.72 (0.48-1.08)    

  Gilsing\[[@R40]\] (Netherlands)   2011 (1986-2002)   340/ 62,573   Total fat\             1.04 (0.73-1.49)\   Age, total energy intake, parity (number of children), and use of oral contraceptives use
                                                                     Animal fat\            1.30 (0.93-1.83)\   
                                                                     Plant fat\             0.64 (0.45-0.91)\   
                                                                     Dairy fat\             1.28 (0.91-1.80)\   
                                                                     Saturated fat\         1.48 (0.94-2.34)\   
                                                                     Monounsaturated fat\   0.90 (0.55-1.46)\   
                                                                     Polyunsaturated fat\   0.89 (0.47-1.01)\   
                                                                     Trans fat              1.51 (1.04-2.20)    
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Total fat {#s2_1}
---------

Eleven case-control and six cohort studies assessed total fat intake and ovarian cancer risk. Summary RR was 1.32 (95% CI = 1.06-1.63, *P* = 0.017) for case-control and 1.10 (95% CI = 0.97-1.24, *P* = 0.25) for cohort studies, with an overall RR of 1.19 (95% CI = 1.04-1.37, *P* = 0.015) for all studies. These results suggested a positive association between total fat intake and ovarian cancer risk. (Figure [2](#F2){ref-type="fig"})

![Relationship between total fat intake and ovarian cancer risk](oncotarget-07-37390-g002){#F2}

Animal fat {#s2_2}
----------

Five case-control and five cohort studies analyzed animal fat intake and ovarian cancer risk. Summary RR was 1.50 (95% CI = 0.89-2.53, *P* = 0.125) for case-control, and 1.09 (95% CI = 0.93-1.28, *P* = 0.272) for cohort studies; the overall RR was 1.21 (95% CI = 0.99-1.47, *P* = 0.065) for all studies. Taken together, these results suggested no association between animal fat intake and ovarian cancer risk. (Figure [3](#F3){ref-type="fig"})

![Relationship between animal fat intake and ovarian cancer risk](oncotarget-07-37390-g003){#F3}

Plant fat {#s2_3}
---------

Four case-control and five cohort studies evaluated plant fat intake and ovarian cancer risk. Summary RR was 0.96 (95% CI = 0.81-1.12, *P* = 0.586) for case-control, and 0.93 (95% CI = 0.74-1.17, *P* = 0.053) for cohort studies, with an overall RR of 0.95 (95% CI = 0.83-1.09, *P* = 0.472). These results suggested no association between plant fat intake and ovarian cancer risk. (Figure [4](#F4){ref-type="fig"})

![Relationship between plant fat intake and ovarian cancer risk](oncotarget-07-37390-g004){#F4}

Saturated fat {#s2_4}
-------------

Seven case-control and six cohort studies assessed saturated fat intake and ovarian risk. Summary RR was 1.11 (95% CI = 0.98-1.27, *P* = 0.147) for case-control, and 1.06 (95% CI = 0.89-1.26, *P* = 0.0.521) for cohort studies; the overall RR was 1.09 (95% CI = 0.98-1.21, *P* = 0.103). After exclusion of 1 study \[[@R29]\] for small bias and sensitivity data, the results changed as follows, respectively, 1.15 (95% CI = 1.02-1.30, *P* = 0.026), 1.06 (95% CI = 0.89-1.26, *P* = 0.521), 1.12 (95%CI = 1.02-1.22, *P* = 0.014), without heterogeneity (Q = 8.54, *P* = 0.577, I2 = 0.0%) between studies. These results suggested a positive association between saturated fat intake and ovarian cancer risk. (Figure [5](#F5){ref-type="fig"})

![Relationship between saturated fat intake and ovarian cancer risk](oncotarget-07-37390-g005){#F5}

Monounsaturated fat {#s2_5}
-------------------

Eight case-control and five cohort studies analyzed monounsaturated fat intake and ovarian cancer risk. Summary RR was 0.96 (95% CI = 0.83-1.12, *P* = 0.477) for case-control, and 1.04 (95% CI = 0.88-1.22, *P* = 0.649) for cohort studies; the overall RR was 0.98 (95% CI = 0.87-1.09, *P* = 0.556) for all studies. These results suggested no association between total fat intake and ovarian cancer risk. (Figure [6](#F6){ref-type="fig"})

![Relationship between monounsaturated fat intake and ovarian cancer risk](oncotarget-07-37390-g006){#F6}

Polyunsaturated fat {#s2_6}
-------------------

Eight case-control and five cohort studies involved polyunsaturated fat intake and ovarian cancer risk. Summary RR was 0.92 (95% CI = 0.81-1.04, *P* = 0.223) for case-control, and 1.06 (95% CI = 0.86-1.31, *P* = 0.570) for cohort studies, with an overall RR of 0.97 (95% CI = 0.86-1.10, *P* = 0.760) for all studies. These findings suggested no association between polyunsaturated fat intake and ovarian cancer risk. (Figure [7](#F7){ref-type="fig"})

![Relationship between polyunsaturated fat intake and ovarian cancer risk](oncotarget-07-37390-g007){#F7}

Dairy fat {#s2_7}
---------

One case-control and five cohort studies assessed dairy fat intake and the risk of ovarian cancer. Summary RR was 1.10 (95% CI = 0.94-1.28, *P* = 0.242) for cohort studies, with an overall RR of 1.05 (95% CI = 0.92-1.19, *P* = 0.478) for all studies. These results suggested no association between dairy fat intake and ovarian cancer risk. (Figure [8](#F8){ref-type="fig"})

![Relationship between dairy fat intake and ovarian cancer risk](oncotarget-07-37390-g008){#F8}

Trans-fat {#s2_8}
---------

Two case-control and two cohort studies evaluated trans-fat intake and ovarian cancer risk. Summary RR was 1.25 (95%CI = 1.06-1.49, *P* = 0.010) for case-control, and 1.24 (95% CI = 0.85-1.81, *P* = 0.285) for cohort studies; the overall RR was 1.25 (95% CI = 1.08-1.44, *P* = 0.002) for all studies. These results suggested a significant positive association between trans-fat intake and ovarian cancer risk. (Figure [9](#F9){ref-type="fig"})

![Relationship between trans fat intake and ovarian cancer risk](oncotarget-07-37390-g009){#F9}

Dietary fat consumption and ovarian cancer subtypes {#s2_9}
---------------------------------------------------

Five studies involved dietary fat intake and risk of ovarian cancer subtypes. Significant positive association was found between total fat, saturated fat, trans-fat intake and serous ovarian tumor risk. High saturated fat intake was associated with a 34% increase in endometroid ovarian cancer risk. The RR for high animal fat intake was 1.36 (95% CI = 1.08-1.73, *P* = 0.011), suggesting a significant positive association between animal fat consumption and mucinous ovarian cancer risk. (Table [3](#T3){ref-type="table"})

###### Relative risks (RR) of ovarian cancer and corresponding 95% confidence intervals (CI) according to histological types and intake of dietary fat

  Types of dietary fat   Histological types                                                                                 
  ---------------------- -------------------- ------- ----------------- ------- ----------------- ------- ----------------- -------
  Total fat              1.12(1.01,1.24)      0.025   1.05(0.85,1.30)   0.628   1.15(0.69,1.90)   0.591   1.17(0.69,1.99)   0.561
  Animal fat             1.07(1.00,1.16)      0.061   0.96(0.79,1.17)   0.715   1.36(1.08,1.73)   0.011   0.82(0.49,1.38)   0.456
  Plant fat              1.07(0.95,1.21)      0.278   0.92(0.76,1.11)   0.391   0.96(0.73,1.27)   0.778   1.22(0.71,2.09)   0.468
  Saturated fat          1.26(1.05,1.52)      0.012   1.34(1.08,1.66)   0.008   1.29(0.93,1.81)   0.132   1.19(0.40,3.51)   0.754
  Monounsaturated fat    0.97(0.82,1.14)      0.692   0.78(0.57,1.06)   0.115   1.09(0.88,1.35)   0.428   0.84(0.58,1.21)   0.350
  Polyunsaturated fat    0.97(0.78,1.21)      0.778   1.07(0.86,1.32)   0.564   1.15(0.93,1.43)   0.203   0.99(0.61,1.62)   0.974
  Dairy fat              0.89(0.72,1.10)      0.283   1.13(0.79,1.61)   0.501   1.17(0.62,2.22)   0.631   0.75(0.44,1.27)   0.287
  Trans fat              1.26(1.02,1.61)      0.044   1.27(0.89,1.81)   0.466   1.33(0.72,2.44)   0.358   1.10(0.64,1.89)   0.729

*P*-value for significant test. (*P* \< 0.050)

Abbreviations: RR: relative risk, CI: confidence interval

Subgroup and sensitivity analysis {#s2_10}
---------------------------------

Subgroup analysis stratified by the geographic areas, study types and confounding factors of included studies was performed. Saturated fat (RR = 1.20, 95% CI = 1.04-1.39) and dairy fat (RR = 1.37, 95% CI = 1.05, 1.79) intake could increase ovarian cancer risk in European populations; a positive trend was present among American populations, while an inverse trend was found in other populations (including Asians and South Americans). The conclusions of case-control and cohort studies were basically consistent; however, cohort studies were more inclined to a positive association between dietary fat intake and ovarian cancer risk, though no statistical significance was obtained. The summary results were modified by menopausal status, hormone replacement therapy, BMI, and pregnancy times. (Table [4-1](#T4a){ref-type="table"} and Table [4-2](#T4b){ref-type="table"}.)

Sensitivity analysis showed that the results obtained for the association between saturated fat intake and ovarian cancer risk were significantly influenced by one study \[[@R29]\], which didn\'t adjust hormone use and pregnancy times.

###### Subgroup analysis based on study characteristics

  ------------------------------------------------------------------------------------------------------------------------------
                                   Total fat   Animal fat            Plant fat                             
  -------------------------------- ----------- --------------------- ----------- --------------------- --- ---------------------
  All studies                      17          1.19(1.04,1.37)\      10          1.21(0.99,1.47)\      9   0.95(0.83,1.09)\
                                               I^2^=60.1%, p=0.001               I^2^=68.6%, p=0.001       I^2^=29.2%, p=0.185

  Study type                                                                                               

  Case-control                     11          1.32(1.06,1.63)\      5           1.50(0.89,2.53)\      4   0.96(0.81,1.12)\
                                               I^2^=69.8%, p=0.000               I^2^=82.3%, p=0.000       I^2^=0.0%, p=0.858

  Cohort                           6           1.10(0.97,1.24)\      5           1.09(0.93,1.28)\      5   0.93(0.74,1.17)\
                                               I^2^=4.2%, p=0.389                I^2^=28.4%, p=0.232       I^2^=61.7%, p=0.034

  Geographic location or country                                                                           

   America                         7           1.08(0.95,1.22)\      5           1.13(0.96,1.34)\      4   0,97(0.85,1.11)\
                                               I^2^=2.7%, p=0.399                I^2^=27.9%, p=0.235       I^2^=0.0%, p=0.805

   Europe                          4           1.25(0.91.1.73)\      2           1.08(0.81,1.44)\      2   0.90(0.48,1.69)\
                                               I^2^=83.5%, P=0.000               I^2^=58.2%, p=0.012       I^2^=89.2%, p=0.002

   Others                          6           1.33(0.98,1.82)\      3           1.69(0.59,4.83)\      3   0.88(0.62,1.09)\
                                               I^2^=63.1%, p=0.019               I^2^=88.1%, p=0.000       I^2^=0.0%, p=0.796

  Adjusted for                                                                                             

   Total energy                                                                                            

   Yes                             12          1.12(0.97,1.29)\      5           1.07(0.87,1.31)\      5   0.90(0.70,1.16)\
                                               I^2^=48.8%, p=0.034               I^2^=48.9%, p=0.098       I^2^=63.2%, p=0.028

   No                              5           1.39(0.99,1.95)\      5           1.55(1.00,2.39)\      4   0.97(0.83,1.13)\
                                               I^2^=62.3%, p=0.001               I^2^=80.1%, p=0.000       I^2^=0.0%, p=0.936

  Family history                                                                                           

   Yes                             5           1.16 (0.93,1.44)\     4           1.17(0.97,1.40)\      4   0.96(0.84,1.10)\
                                               I^2^=44.7%, p=0.143               I^2^=28.0%, p=0.244       I^2^=29.2%.p=0.185

   No                              12          1.20(1.00,1.43)\      6           1.27(0.89,1.82)\      5   0.93(0.71,1.22)\
                                               I^2^=67.8%, p=0.000               I^2^=79.3%, p=0.000       I^2^=59.4%, p=0.043

  OC use                                                                                                   

   Yes                             12          1.28(1.09,1.51)\      6           1.11(0.97,1.29)\      6   0.96(0.82,1.14)\
                                               I^2^=65.9%, p=0.001               I^2^=37.1%, p=0.159       I^2^=49.2%, p=0.080

   No                              5           0.98(0.79,1.22)\      4           1.49(0.69,3.21)\      3   0.85(0.61,1.17)\
                                               I^2^=31.5%, p=0.211               I^2^=84.2%, p=0.000       I^2^=0.0%, p=0.716

  BMI                                                                                                      

   Yes                             6           1.57(1.24,1.99)\      3           2.08(1.04,4.14)\      2   1.00(0.81,1.25)\
                                               I^2^=56.3%, p=0.043               I^2^=81.5%, p=0.004       I^2^=29.2%, p=0.185

   No                              11          1.04(0.94,1.16)\      7           1.03(0.90,1.18)\      7   0.92(0.77,1.10)\
                                               I^2^=17.3%, p=0.284               I^2^=22.0%, p=0.261       I^2^=46.5%, p=0.082

  Menopausal status                                                                                        

   Yes                             9           1.20(0.95,1.51)\      4           1.29(0.80,2.08)\      4   1.08(0.90,1.30)\
                                               I^2^=75.2%, p=0.000               I^2^=82.5%, p=0.001       I^2^=8.4%, p=0.351

   No                              8           1.17(0.99,1.38)\      6           1.21(0.98,1.49)\      5   0.89(0.76,1.05)\
                                               I^2^=38.7%, p=0.121               I^2^=50.0%, p=0.075       I^2^=25.7%, p=0.185

  Hormone use                                                                                              

   Yes                             3           1.08(0.85,1.37)\      2           1.15(0.85,1.55)\      2   0.99(0.81,1.21)\
                                               I^2^=41.7%, p=0.180               I^2^=48.3%,0.164          I^2^=0.0%, p=0.982

   No                              14          1.23(1.04,1.45)\      8           1.25(0.97,1.62)\      7   0.92(0.76,1.11)\
                                               I^2^=66.6%, p=0.000               I^2^=73.4%, p=0.000       I^2^=46.7%, p=0.081

  Pregnancy times                                                                                          

   Yes                             9           1.10(0.98,1.25)\      6           1.05(0.8,1.23)\       6   0.90(0.73,1.11)\
                                               I^2^=15.7%, p=0.303               I^2^=33.5%, p=0.185       I^2^=0.0%, p=0.990

   No                              8           1.33(1.01,1.74)\      4           1.64(1.00,2.69)\      3   1.00(0.83,1.21)\
                                               I^2^=78.2%, p=0.000               I^2^=80.6%, p=0.001       I^2^=55.4%, p=0.047
  ------------------------------------------------------------------------------------------------------------------------------

###### Subgroup analysis based on study characteristics

  -------------------------------------------------------------------------------------------------------------------------------------
                                Monounsaturated fat   Polyunsaturated fat   Dairy fat                             
  ----------------------------- --------------------- --------------------- ----------- --------------------- --- ---------------------
  All studies                   13                    0.98(0.87,1.09)\      13          0.97(0.86,1.11)\      6   1.05(0.92,1.19)\
                                                      I^2^=42.6%, p=0.052               I^2^=48.9%, p=0.024       I^2^=16.3%, p=0.309

  Study type                                                                                                      

  Case-control                  8                     0.96(0.83,1.12)\      8           0.93(0.82,1.05)\      1   0.95(0.79,1.14)
                                                      I^2^=55.2%, p=0.029               I^2^=26.7%, p=0.216       

  Cohort                        5                     1.04(0.88,1.22)\      5           1.06(0.86,1.31)\      5   1.10(0.94,1.28)\
                                                      I^2^=4.5, p=0.381                 I^2^=49.8%, p=0.093       I^2^=13.7%, p=0.327

  Geographic location/country                                                                                     

   America                      6                     0.98(0.85,1.13)\      6           0.97(0.76,1.25)\      4   0.98(0.86,1.10)\
                                                      I^2^=0.0%, p=0.507                I^2^=57.9%, p=0.050       I^2^=0.0%, p0.937

   Europe                       4                     0.92(0.77,1.10)\      4           1.03(0.89,1.19)\      2   1.37(1.05,1.79)\
                                                      I^2^=56.4%, p=0.076               I^2^=35.3%, p=0.200       I^2^=0.0%, p=0.524

   Others                       3                     1.00(0.72,1.38)\      3           0.92(0.65,1.32)\      0   
                                                      I^2^=67.1%, p=0.048               I^2^=68.8%, p=0.041       

  Adjust for                                                                                                      

   Total energy                                                                                                   

   Yes                          9                     0.98(0.84,1.14)\      9           099(0.84,1.17)\       4   1.03(0.87,1.23)\
                                                      I^2^=47.8%, p=0.063               I^2^=59.2%, p=0.016       I^2^=30.4%, p=0.230

   No                           4                     0.93(0.79,1.10)\      4           0.93(0.80,1.08)\      2   1.10(0.88,1.37)\
                                                      I^2^=32.4%, p=0.218               I^2^=14.6%, p=0.319       I^2^=21.3%, p=0.260

  Family history                                                                                                  

   Yes                          4                     1.00(0.84,1.19)\      4           0.92(0.73,1.15)\      2   0.97(0.84,1.12)\
                                                      I^2^=29.0%, p=0.238               I^2^=60.8%, p=0.054       I^2^=0.0%, p=0.684

   No                           9                     0.95(0.82,1.11)\      9           1.02(0.88,1.18)\      4   1.15(0.94,1.41)\
                                                      I^2^=50.6%, p=0.048               I^2^=42.9%, p=0.092       I^2^=25.1%, p=0.684

  OC use                                                                                                          

   Yes                          8                     0.99(0.89,1.10)\      8           1.00(0.86,1.15)\      5   1.08(0.93,1.25)\
                                                      I^2^=26.4%, p=0.227               I^2^=55.9%, p=0.034       I^2^=27.3%, p=0.239

   No                           5                     0.90(0.68,1.20)\      5           0.93(0.71,1.21)\      1   0.94(0.70,1.27)
                                                      I^2^=61.0%, p=0.036               I^2^=53.8%, p=0.070       

  BMI                                                                                                             

   Yes                          9                     1.20(0.94,1.52)\      9           1.27(1.03,1.58)\      1   0.94(0.70,1.27)
                                                      I^2^=0.0%, p=0.709                I^2^=0.0%, p=0.984        

   No                           4                     0.93(0.83,1.05)\      4           0.93(0.82,1.05)\      5   1.08(0.93,1.25)\
                                                      I^2^=47.0%, p=0.058               I^2^=49.8%, p=0.043       I^2^=27.3%, p=0.239

  Menopausal status                                                                                               

   Yes                          6                     1.01(0.83,1.23)\      5           1.10(0.87,1.39)\      3   1.00(0.85,1.18)\
                                                      I^2^=53.9%p=0.070                 I^2^=53.3%, p=0.093       I^2^=0.0%, p=0.876

   No                           7                     0.93(0.81,1.08)\      8           0.92(0.82,1.02)\      3   1.17(0.88,1.57)\
                                                      I^2^=38.2%, p=0.138               I^2^=16.6%, p=0.299       I^2^=62.6%, p=0.069

  Hormone use                                                                                                     

   Yes                          2                     1.05(0.79,1.39)\      2           1.22(0.95,1.55)\      2   0.98(0.78,1.24)\
                                                      I^2^=0.0%, p=0.847                I^2^=0.0%, p=0.642        I^2^=0.0%, p=0.622

   No                           11                    0.96(0.84,1.09)\      11          0.95(0.83,1.08)\      4   1.10(0.91,1.32)\
                                                      I^2^=52.0%, p=0.027               I^2^=52.3%, p=0.026       I^2^=45.5%, p=0.139

  Pregnancy times                                                                                                 

   Yes                          8                     1.02(0.89,1.17)\      8           0.93(0.78,1.12)\      3   1.02(0.88,1.18)\
                                                      I^2^=38.6%, p=0.122               I^2^=62.9%, p=0.009       I^2^=12.2%, p=0.320

   No                           5                     0.87(0.77,0.98)\      5           1.02(0.90,1.17)\      3   1.11(0.85,1.46)\
                                                      I^2^=0.0%, p=0.047                I^2^=0.0%, p=0.405        I^2^=40.6%, p=0.186
  -------------------------------------------------------------------------------------------------------------------------------------

*P*-value for heterogeneity within each subgroup.

Publication bias {#s2_11}
----------------

We found no evidence of publication bias with regard to dietary fat consumption and ovarian cancer risk by means of visual inspection of funnel plots and formal statistical tests, including Begg rank correlation test and Egger linear regression test (all *P* \> 0.05).

DISCUSSION {#s3}
==========

Dietary fat, as one of the most controversial dietary factors in nutritional epidemiology, might elevate the incidence of hormone related cancers, including breast, endometrial and ovarian cancers, but discrepant observational results have been reported. We thoroughly searched the literature, and found the incidence of two important cancer types, breast cancer and stomach cancer, were in relation to the high consumption of dietary fat. Breast cancer was traditionally considered to be linked with western lifestyles, other including prostate and colorectal cancers, and the inflammatory bowel diseases; IBD, Crohn\'s disease (CD). Stomach cancer was considered to be linked more with eastern lifestyle. The included two meta-analyses \[[@R7], [@R8]\] indicated positive associations between dietary fat intake and breast and stomach cancer. Considering the regional difference of these two cancers, we can conclude that the effect of dietary fat on cancer risk may be independent of the region. To define the effect of dietary fat on ovarian cancer risk, we conducted this meta-analysis to clear this research subject.

The results of this meta-analysis including case-control and cohort studies indicated that consumption of total dietary fat and trans fat increased the risk of ovarian cancer. These findings were consistent with the results in specific epidemical studies in NIH-AARP cohort study \[[@R35]\] and an earlier meta-analysis \[[@R11]\], which reported positive associations between total fat intake and EOC risk. Contrasted with our meta-analysis, a pooled analysis \[[@R12]\], three cohort studies \[[@R34], [@R39], [@R40]\] and several case-control studies \[[@R20], [@R24], [@R27], [@R29]\] observed no association between total fat consumption and EOC risk. Consistent with a pooled analysis \[[@R12]\] of 12 cohort studies, we observed no significant associations of consumption of dietary fat and risk of ovarian cancer subtypes. There was also no relevance in the associations with dietary fat intake and the risk of different histological subtypes of EOC in an American case-control study \[[@R27]\] and an Italian case-control study \[[@R30]\]. Limited studies involved in associations between dietary fat intakes and EOC risk attribute to different histological subtypes of EOC. Merritt \[[@R34]\] (EPIC) reported high intake of polyunsaturated fatty acids can increase risk for serous EOC. Blank \[[@R35]\] observed an increased risk of serous EOC by total energy from animal fat and inverse associations with risk of EOC observed for the intakes of plant fat and polyunsaturated FAs. Beral \[[@R49]\] reported that serous subtype appeared to have more consistent global distribution, followed by endometrioid subtype, whereas mucinous and clear cell subtypes varied significantly across countries. Among these four main subtypes, the clear cell subtype was least studied, which has higher prevalence in Asia \[[@R50]--[@R52]\] and was more frequently found in younger women \[[@R52]\]. In the current meta-analysis, there was only one study \[[@R27]\] from America involving ovarian clear cell carcinoma (OCCC). In addition, the survival outcome of OCCC was comparable to that of serous EOC in terms of early-stage disease \[[@R50], [@R53]--[@R55]\], but worse with respect to advanced-stage disease \[[@R56]--[@R62]\]. Therefore, more studies, including epidemiological and clinical studies, should be carried out in Asia and other "new regions" (Central and South America, Africa) \[[@R63]\].

Subgroup analysis based on the characteristics of included studies suggested that menopausal status, hormone replacement therapy, BMI, and pregnancy times can modify the association between dietary fat intake and ovarian cancer risk. These factors are related to exposure to estrogens \[[@R64], [@R65]\]. A reanalysis \[[@R49]\] of epidemiological data suggested estrogen monotherapy or estrogen and progesterone combination therapy could elevate the risk of ovarian cancer, specifically serous or endometroid tumors. In ovarian tissues, estrogen receptors are also expressed \[[@R66]\]; the ratios of estrogen-DNA adduct depurination to estrogen metabolites and conjugates in ovarian cancer cases are significantly higher than controls \[[@R67]\]. We speculated that hormonal pathways might play a positive role in the development of ovarian cancer. High consumption of dietary fat could stimulate the secretion of extra ovarian estrogen \[[@R68], [@R69]\], which can exert tumor-promoting activity *via* mitogenic effects on ERα- positive \[[@R70], [@R71]\] or negative \[[@R72]\] tumor cells, therefore increasing the risk of ovarian cancer \[[@R66]\]. What\'s more, obese women may suffer from insulin resistance, and concurrent hyperinsulinemia with excess insulin-like growth factor-1 receptor (IGF-1) could additionally induce androgen steroidogenesis \[[@R73]\] and lead to tumor development \[[@R74], [@R75]\].

An important highlight of our meta-analysis is that we analyzed the association between dietary fat intake and the risk of ovarian cancer subtypes. We found that serous ovarian cancer incidence was more susceptible to dietary fat intake. However, these results should be interpreted with caution. The insufficient number of included cases and potential misclassification of pathological subtypes may contribute to the statistical difference observed.

Several limitations of this meta-analysis should be considered. First, there was substantial heterogeneity across studies assessing the associations of dietary fat intake with ovarian cancer risk. Considering the varieties of the characteristics of included populations, and study designs and types, the existence of substantial heterogeneity was reasonable, and we conducted subgroup analysis to reduce its effect on the results. Second, misclassification bias, which stemmed mainly from the misclassification of dietary assessments and pathological subtypes of ovarian cancer, should be paid enough attention to. Misclassification of dietary assessments may result from the differences across nutrient databases or designed questionnaires. Diagnosis, pathology review, and classification methods could cause misclassification bias of pathological subtypes of ovarian cancer. Third, we couldn\'t rule out the effects of confounding factors and various statistical biases on our results. Furthermore, controls and confounding factor adjustment methods across individual studies were not consistent. With more and more basic and clinical researches in recent years, and the increasing understanding of the relationship between diet and health, the confounding factors controlled have markedly increased in number, and bias was inevitable. Forth, although no publication bias was found, its possible effect cannot be totally excluded.

In conclusion, the present meta-analysis of case-control and cohort studies indicate that increased consumption of total fat, saturated fat and trans-fat may be associated with an increased risk of ovarian cancer. Among the dietary fats, saturated fats can significantly increase serous and endometroid ovarian cancer, with the risk of serous ovarian cancer more susceptible to dietary fat intake. In addition, subgroup analysis data suggested that menopausal status, hormone replacement therapy, BMI, and pregnancy times may serve as potential effect modifiers. Future studies should focus more on specific pathological subtypes of ovarian cancer as well as the influence of molecular mechanisms and genetic factors on the association of dietary fat and ovarian cancer.

MATERIALS AND METHODS {#s4}
=====================

Search strategy {#s4_1}
---------------

We obtained the literature published in any language to December 2015 by fully searching the PubMed database. The search terms used were "diet", "dietary fat" in combination with "ovarian cancer," "ovarian neoplasm" or "ovarian carcinoma", without restrictions. In addition, we reviewed the reference lists of retrieved studies and recent reviews to supplement electronic database searches.

Study selection {#s4_2}
---------------

Study selection included initial screening of titles or abstracts, and a second one for full texts. Studies were eligible for inclusion if they met the following criteria: 1) observational studies which enrolled patients with proven epithelial ovarian cancers excluding tumors of "borderline malignant potential" histopathology, 2) patients enrolled were adults (≥18 yr of age), 3) studies containing available data showing association(s) between intake of dietary fat (total, saturated, animal, dairy or unsaturated fat) and ovarian cancer, and 4) odds ratio or relative risk (RR) with 95% confidence interval (CI) for each variable or availability of raw data to calculate these parameters.

Data extraction {#s4_3}
---------------

All data were extracted with a data-collection form. Information was recorded as follows: last name of the first author, publication year, study population, period, country, sample size; risk estimate from multivariable model for the highest *versus* lowest category of dietary fat intake with the corresponding 95% CI; statistical adjustment for the main confounding factors of interest.

Data extraction and study selection were performed by 3 authors (Qiu WL, Lu H and Qi YN) independently. Any disagreements were resolved by discussion.

Statistical methods {#s4_4}
-------------------

The association between dietary fat consumption and the risk of ovarian cancer was our main analytical object. Dietary fats in this meta-analysis were defined as total fat, animal fat, plant fat, dairy fat, saturated fat, monounsaturated fat, polyunsaturated fat and trans-fat. Relative risk (RR) was used as the common measure of association in this meta-analysis, and the random-effects model was selected to calculate summary RRs and 95% CIs associated with dietary fats. Q statistic (significance level at *P* \< 0.10) and I^2^ statistic, a quantitative measure of inconsistency across studies \[[@R13]\], were applied for heterogeneity assessment of RRs across studies. Subgroup analyses stratified by geographic region (country), study type, and study characteristics were carried out to investigate potential sources of heterogeneity. Sensitivity analyses were performed by excluding one study at a time to assess the influence of a single study on the overall risk estimate. Publication bias was assessed with funnel plots, Egger\'s test \[[@R14]\], and Begg\'s test \[[@R15]\] (all *P* \> 0.05). The Stata version 12.0 software (StataCorp) was used for statistical analyses.
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EOC

:   epithelial ovarian cancer

RR

:   relative risk

OR

:   odds ratio

CI

:   confidential interval

BMI

:   body mass index.
